The FDA has released its draft regulations on the use of a new pill that can be taken to prevent pregnancy after sex.
The new pill, called the Mirena Cervarix, was approved by the Food and Drug Administration (FDA) for use in women after sex and for prevention of pregnancy.
The agency said it will make final recommendations to the White House and Congress on the drug’s effectiveness and safety by mid-March.
The FDA approved the pill in July 2016 and has said it expects to make its final recommendations on the safety and effectiveness of the drug next spring.
The drug is also approved to treat menopausal symptoms, but the agency has not yet said whether the pill can be used to prevent or treat postpartum hemorrhage.
The FDA did not give a timeframe for when the new drug could be on the market.
The drugs approval came in response to public concerns that the pill could be harmful to women’s health and could be a danger to the unborn baby.
The new FDA regulations say the pill should be taken by anyone who is at least 17 years old.
The drug can be given as an injection or as a patch, or taken in pills or a tablet.
The pill contains three different types of active ingredients: a progestin, a hormone that stimulates ovulation, and a synthetic form of the hormone called norethindrone.
It also contains a form of another progestogen, called DHEA, that is thought to help with vaginal bleeding and uterine contractions.
The first pill, the Cervaro, was released in November 2016.
The second pill, known as the Mifegymiso, was initially released in February 2017.
The Mirene was approved in December 2016, but was not available until May 2017.
The pills are available in the U.S. and in Canada.
The next major new pill is the Lactobacillus rhamnosus, or LBR, a combination of Lactococcus and Lactoferrin, which is used to treat bacterial infections.
The LBR was approved last fall.
It was approved for use to treat urinary tract infections and menopausal and urinary tract problems, but not for pregnancy prevention.
The pill was approved to prevent and treat hemorrhage and pain during childbirth, which can occur if a woman has a miscarriage.
The third pill, also approved for birth control, is called the Diflucan.
It was approved earlier this year.
The last major new birth-control pill, a newer drug called the Levonorgestrel, was originally approved in 2015 and is now available for women to use as an emergency birth control method.
It is used in the United States to prevent ovulation in women over 40.
The pills were approved for women at least 35 years old and to treat a sexually transmitted infection, which was not part of the FDA approval process.
The agency has said the pill will be available for use for women ages 19 to 44, but does not have a timeline for its release.
The U.N. Population Fund has called for the agency to expand its use of the pills to prevent complications for women.
The Drug Enforcement Administration has also announced it will consider expanding its use to prevent preterm birth, but has not said whether it will also make its recommendation to Congress.